Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2803484325;84326;84327 chr2:178562032;178562031;178562030chr2:179426759;179426758;179426757
N2AB2639379402;79403;79404 chr2:178562032;178562031;178562030chr2:179426759;179426758;179426757
N2A2546676621;76622;76623 chr2:178562032;178562031;178562030chr2:179426759;179426758;179426757
N2B1896957130;57131;57132 chr2:178562032;178562031;178562030chr2:179426759;179426758;179426757
Novex-11909457505;57506;57507 chr2:178562032;178562031;178562030chr2:179426759;179426758;179426757
Novex-21916157706;57707;57708 chr2:178562032;178562031;178562030chr2:179426759;179426758;179426757
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-142
  • Domain position: 72
  • Structural Position: 155
  • Q(SASA): 0.3905
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs1243085385 None 0.998 N 0.446 0.343 0.240491677333 gnomAD-4.0.0 6.84403E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99562E-07 0 0
E/V None None 0.733 N 0.49 0.209 0.324161360171 gnomAD-4.0.0 1.20033E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31251E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1972 likely_benign 0.2222 benign -0.873 Destabilizing 0.989 D 0.515 neutral N 0.476159672 None None N
E/C 0.7911 likely_pathogenic 0.8208 pathogenic -0.711 Destabilizing 1.0 D 0.804 deleterious None None None None N
E/D 0.1699 likely_benign 0.1819 benign -1.544 Destabilizing 0.998 D 0.379 neutral N 0.499479248 None None N
E/F 0.6692 likely_pathogenic 0.6853 pathogenic -1.035 Destabilizing 0.999 D 0.813 deleterious None None None None N
E/G 0.2337 likely_benign 0.2736 benign -1.22 Destabilizing 0.999 D 0.703 prob.neutral N 0.502980914 None None N
E/H 0.4051 ambiguous 0.4304 ambiguous -1.274 Destabilizing 1.0 D 0.645 neutral None None None None N
E/I 0.3298 likely_benign 0.3264 benign 0.074 Stabilizing 0.995 D 0.729 prob.delet. None None None None N
E/K 0.203 likely_benign 0.2347 benign -0.9 Destabilizing 0.998 D 0.446 neutral N 0.501498046 None None N
E/L 0.3507 ambiguous 0.3779 ambiguous 0.074 Stabilizing 0.983 D 0.678 prob.neutral None None None None N
E/M 0.397 ambiguous 0.4143 ambiguous 0.544 Stabilizing 1.0 D 0.795 deleterious None None None None N
E/N 0.3105 likely_benign 0.3187 benign -1.152 Destabilizing 1.0 D 0.659 neutral None None None None N
E/P 0.9522 likely_pathogenic 0.9605 pathogenic -0.221 Destabilizing 1.0 D 0.791 deleterious None None None None N
E/Q 0.1378 likely_benign 0.1475 benign -0.985 Destabilizing 0.999 D 0.609 neutral N 0.477333108 None None N
E/R 0.3148 likely_benign 0.3723 ambiguous -0.908 Destabilizing 1.0 D 0.665 neutral None None None None N
E/S 0.1871 likely_benign 0.2034 benign -1.639 Destabilizing 0.996 D 0.511 neutral None None None None N
E/T 0.1796 likely_benign 0.1866 benign -1.319 Destabilizing 0.998 D 0.718 prob.delet. None None None None N
E/V 0.21 likely_benign 0.2127 benign -0.221 Destabilizing 0.733 D 0.49 neutral N 0.479506621 None None N
E/W 0.8744 likely_pathogenic 0.897 pathogenic -1.161 Destabilizing 1.0 D 0.783 deleterious None None None None N
E/Y 0.5632 ambiguous 0.5778 pathogenic -0.839 Destabilizing 1.0 D 0.813 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.